🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the efficacy, safety and tolerabilit...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2015-02
Trial ID
NCT02342886
The trial will evaluate the extended bactericidal activity of 14 consecutiv...
Status
Completed
Location
Centre for Tuberculosis Research Innovation, UCT Lung Institute
Start Date
2012-10
Trial ID
NCT01691534
Treatments Being Tested
To evaluate the efficacy, safety and tolerability of various doses and dura...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2017-11-21
Trial ID
NCT03086486
Treatments Being Tested
The purpose of this study is to determine the mycobactericidal activity of ...
Status
Completed
Location
The Aurum Institute: Tembisa Hospital
Start Date
2014-10-23
Trial ID
NCT02193776
This is a Phase 1, single-center, randomized, balanced, single-dose, two-tr...
Status
Completed
Location
MDS Pharma Services
Start Date
2007-03
Trial ID
NCT01828827
Treatments Being Tested
This will be a Phase 1, single-center, randomized, balanced, single-dose, t...
Status
Completed
Location
MDS Pharma Services (Celerion)
Start Date
2009-09
Trial ID
NCT01830439
Treatments Being Tested
The trial will evaluate the extended bactericidal activity of 14 consecutiv...
Status
Completed
Location
Centre for Tuberculosis Research Innovation, UCT Lung Institute
Start Date
2010-10
Trial ID
NCT01215851
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety, tolerability...
Status
Completed
Location
Task Applied Science - Brooklyn Chest Hospital
Start Date
2015-03
Trial ID
NCT02333799
Treatments Being Tested
The current treatment regimen for MDR-TB has poor outcomes and costs of tre...
Status
Completed
Location
Republican Scientific and Practical Centre for Pulmonology and Tuberculosis hospital
Start Date
2020-10-20
Trial ID
NCT04207112
Treatments Being Tested
This is a Phase 1, single dose (200 mg), open-label study comparing the pha...
Status
Terminated
Location
Saint Louis University Center for Vaccine Development
Start Date
2018-03-29
Trial ID
NCT02422524
Treatments Being Tested